• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟酸和阿昔莫司对脂蛋白(a)浓度及代谢的影响。

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover.

作者信息

Seed M, O'Connor B, Perombelon N, O'Donnell M, Reaveley D, Knight B L

机构信息

Department of Medicine, Charing Cross and Westminster Medical School, London, UK.

出版信息

Atherosclerosis. 1993 Jun;101(1):61-8. doi: 10.1016/0021-9150(93)90102-z.

DOI:10.1016/0021-9150(93)90102-z
PMID:8216503
Abstract

This study examines the effect of nicotinic acid (1 g t.d.s.) on serum Lp(a) concentration in a group of patients with type II hyperlipidaemia selected on the basis of a plasma Lp(a) concentration greater than 30 mg/dl. Reductions in total cholesterol, triglyceride, LDL-cholesterol and Lp(a) were 16.3%, 25.5%, 23.7% and 36.4%, respectively, with an increase in HDL cholesterol of 37.3%. The reduction in Lp(a) concentration did not correlate with any other lipoprotein changes. In order to establish the mechanism of the fall in Lp(a) concentration, in vivo turnover of autologous Lp(a) was studied in three subjects before and whilst taking nicotinic acid. The fractional catabolic rate in Lp(a) was unaltered in the subjects on therapy, indicating that nicotinic acid did not increase catabolism of Lp(a) but decreased the synthetic rate. Since nicotinic acid was poorly tolerated we examined the effect of acipimox, an analogue of nicotinic acid on lipoproteins using a placebo controlled double-blind crossover design in a group of hyperlipidaemic patients again selected with plasma Lp(a) concentration greater than 30 mg/dl. Acipimox was better tolerated than nicotinic acid but the percentage changes in lipoprotein concentrations were smaller.

摘要

本研究在一组基于血浆Lp(a)浓度大于30mg/dl入选的II型高脂血症患者中,检测了烟酸(每日3次,每次1g)对血清Lp(a)浓度的影响。总胆固醇、甘油三酯、低密度脂蛋白胆固醇和Lp(a)分别降低了16.3%、25.5%、23.7%和36.4%,高密度脂蛋白胆固醇升高了37.3%。Lp(a)浓度的降低与其他任何脂蛋白变化均无相关性。为了确定Lp(a)浓度下降的机制,在3名受试者服用烟酸之前及期间,对自体Lp(a)的体内周转率进行了研究。接受治疗的受试者中Lp(a)的分数分解代谢率未改变,这表明烟酸并未增加Lp(a)的分解代谢,而是降低了合成率。由于烟酸耐受性较差,我们采用安慰剂对照双盲交叉设计,在另一组同样基于血浆Lp(a)浓度大于30mg/dl入选的高脂血症患者中,检测了烟酸类似物阿昔莫司对脂蛋白的影响。阿昔莫司的耐受性优于烟酸,但脂蛋白浓度的变化百分比更小。

相似文献

1
The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover.烟酸和阿昔莫司对脂蛋白(a)浓度及代谢的影响。
Atherosclerosis. 1993 Jun;101(1):61-8. doi: 10.1016/0021-9150(93)90102-z.
2
A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia.阿昔莫司与烟酸治疗2b型高脂血症的比较。
Br J Clin Pharmacol. 1992 Apr;33(4):451-3. doi: 10.1111/j.1365-2125.1992.tb04067.x.
3
Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects.
Braz J Med Biol Res. 2001 Feb;34(2):177-82. doi: 10.1590/s0100-879x2001000200004.
4
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.降脂药物联合治疗对冠心病且胆固醇水平“正常”患者的影响。一项随机、安慰剂对照试验。哈佛动脉粥样硬化逆转项目(HARP)研究组。
Ann Intern Med. 1996 Oct 1;125(7):529-40. doi: 10.7326/0003-4819-125-7-199610010-00001.
5
New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug.烟酸用于治疗高脂血症的新进展:对一种老药应用的新思考。
Coron Artery Dis. 1996 Apr;7(4):321-6. doi: 10.1097/00019501-199604000-00009.
6
Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy.烟酸受体、羟基羧酸受体2中的基因编码变体以及对烟酸治疗的反应。
Pharmacogenet Genomics. 2017 Aug;27(8):285-293. doi: 10.1097/FPC.0000000000000289.
7
Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype.烟酸/拉罗匹仑对脂蛋白(a)浓度的影响与基线脂蛋白(a)浓度和 LPA 基因型有关。
Metabolism. 2014 Mar;63(3):365-71. doi: 10.1016/j.metabol.2013.10.014. Epub 2013 Nov 6.
8
The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemia.
J Intern Med. 1997 Feb;241(2):151-5.
9
Lipoprotein (a) concentrations in patients with various dyslipidaemias.不同血脂异常患者的脂蛋白(a)浓度。
Ann Med. 1997 Aug;29(4):305-9. doi: 10.3109/07853899708999352.
10
Pentaerythritol tetranicotinate (niceritrol) decreases plasma lipoprotein(a) levels.季戊四醇四烟酸酯(烟酸戊四醇酯)可降低血浆脂蛋白(a)水平。
Metabolism. 1997 Apr;46(4):355-8. doi: 10.1016/s0026-0495(97)90046-9.

引用本文的文献

1
Lipoprotein(a) Lowering-From Lipoprotein Apheresis to Antisense Oligonucleotide Approach.降低脂蛋白(a)——从脂蛋白分离术到反义寡核苷酸疗法
J Clin Med. 2020 Jul 3;9(7):2103. doi: 10.3390/jcm9072103.
2
[Dyslipidemias : Diagnostics and management].[血脂异常:诊断与管理]
Herz. 2017 Sep;42(6):607-620. doi: 10.1007/s00059-017-4601-2.
3
Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention.脂蛋白(a)与冠状动脉造影或经皮冠状动脉介入治疗后的长期死亡率的关联。
Clin Cardiol. 2017 Sep;40(9):674-678. doi: 10.1002/clc.22712. Epub 2017 Apr 26.
4
Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatment.动脉粥样硬化的病理生理学与治疗:脂蛋白修饰治疗的当前观点与未来展望
Neth Heart J. 2017 Apr;25(4):231-242. doi: 10.1007/s12471-017-0959-2.
5
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).SCARB1基因变异与高高密度脂蛋白胆固醇和高脂蛋白(a)合并表型相关。
Circ Cardiovasc Genet. 2016 Oct;9(5):408-418. doi: 10.1161/CIRCGENETICS.116.001402. Epub 2016 Sep 20.
6
Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.血浆脂蛋白(a)与有早发冠心病家族史的健康非洲裔美国人的亚临床冠状动脉斑块体积、三支血管和左主干冠状动脉疾病以及严重冠状动脉狭窄的关系。
Am J Cardiol. 2016 Sep 1;118(5):656-61. doi: 10.1016/j.amjcard.2016.06.020. Epub 2016 Jul 5.
7
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state.早期肾衰竭作为一种心血管疾病:关注脂蛋白(a)和血栓前状态。
World J Nephrol. 2015 Jul 6;4(3):374-8. doi: 10.5527/wjn.v4.i3.374.
8
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans.单克隆抗体阻断白细胞介素-6可抑制人类载脂蛋白(a)的表达及脂蛋白(a)的合成。
J Lipid Res. 2015 May;56(5):1034-42. doi: 10.1194/jlr.P052209. Epub 2015 Feb 21.
9
Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial.健康饮食干预与脂蛋白(a)血浆水平:Omni Heart试验结果
PLoS One. 2014 Dec 15;9(12):e114859. doi: 10.1371/journal.pone.0114859. eCollection 2014.
10
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.聚(ADP-核糖)聚合酶与 Sirtuin 酶之间的串扰。
Mol Aspects Med. 2013 Dec;34(6):1168-201. doi: 10.1016/j.mam.2013.01.004. Epub 2013 Jan 25.